Status:
ACTIVE_NOT_RECRUITING
A Genome-Wide Association Study for Neonatal Diseases
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Neonatal Disease
Necrotizing Enterocolitis
Eligibility:
All Genders
Brief Summary
This is an observational study to identify genetic risks for neonatal diseases, necrotizing enterocolitis (NEC) using genome-wide association study (GWAS) and enterotype investigation. We hypothesize ...
Detailed Description
NEC is the most frequently encountered surgical emergencies and a life-threatening disease that predominantly affects preterm neonates. The incidence is estimated to be 7-10% in ver low birth weight (...
Eligibility Criteria
Inclusion
- Chinese infants admitted in the neonatal unit (NNU)
Exclusion
- Refuse consent for study
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT04074824
Start Date
September 1 2018
End Date
October 31 2026
Last Update
June 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong